Heparanase Inhibition Prevents Liver Steatosis in E(0) Mice

Background: Non-alcoholic fatty liver disease affects up to 30% of adults in the USA, and is associated with a higher incidence of chronic liver morbidity and mortality. Several molecular pathways are involved in the pathology of liver steatosis, including lipid uptake, lipogenesis, lipolysis, and b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinaneh, Safa, Hijaze, Walaa, Mansour-Wattad, Lana, Hammoud, Rawan, Zaidani, Hisam, Kabala, Aviva, Hamoud, Shadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954723/
https://www.ncbi.nlm.nih.gov/pubmed/35329997
http://dx.doi.org/10.3390/jcm11061672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954723/
https://www.ncbi.nlm.nih.gov/pubmed/35329997
http://dx.doi.org/10.3390/jcm11061672

Ejemplares similares